| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activation of G-proteins in brain by endogenous and exogenous cannabinoids
|
Childers, Steven R.
|
|
2006
|
8 |
1 |
p. E112-E117
|
artikel
|
| 2 |
Blood pressure as an example of a biomarker that functions as a surrogate
|
Desai, Mehul
|
|
2006
|
8 |
1 |
p. E146-E152
|
artikel
|
| 3 |
CNS drug delivery: Opioid peptides and the blood-brain barrier
|
Witt, Ken A.
|
|
2006
|
8 |
1 |
p. E76-E88
|
artikel
|
| 4 |
Commentary: Where and how could biomarkers be used in 2016
|
Austin, M. J. Finley
|
|
2006
|
8 |
1 |
p. E185-E189
|
artikel
|
| 5 |
Current industrial practices of assessing permeability and P-glycoprotein interaction
|
Balimane, Praveen V.
|
|
2006
|
8 |
1 |
p. E1-E13
|
artikel
|
| 6 |
Current status of immunologic approaches to treating tobacco dependence: Vaccines and nicotine-specific antibodies
|
LeSage, Mark G.
|
|
2006
|
8 |
1 |
p. E65-E75
|
artikel
|
| 7 |
Cytochrome P450s and other enzymes in drug metabolism and toxicity
|
Guengerich, F. Peter
|
|
2006
|
8 |
1 |
p. E101-E111
|
artikel
|
| 8 |
Detergent-resistant membrane microdomains in the disposition of the lipid signaling molecule anandamide
|
McFarland, Matthew J.
|
|
2006
|
8 |
1 |
p. E95-E100
|
artikel
|
| 9 |
Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse
|
Carroll, F. Ivy
|
|
2006
|
8 |
1 |
p. E196-E203
|
artikel
|
| 10 |
Effect of N-1 and N-2 residues on peptide deamidation rate in solution and solid state
|
Li, Bei
|
|
2006
|
8 |
1 |
p. E166-E173
|
artikel
|
| 11 |
Genetic factors in the predisposition to drug-induced hypersensitivity reactions
|
Pirmohamed, Munir
|
|
2006
|
8 |
1 |
p. E20-E26
|
artikel
|
| 12 |
Mechanisms of drug-induced liver injury
|
Holt, Michael P.
|
|
2006
|
8 |
1 |
p. E48-E54
|
artikel
|
| 13 |
Molecular recognition of opioid receptor ligands
|
Kane, Brian E.
|
|
2006
|
8 |
1 |
p. E126-E137
|
artikel
|
| 14 |
Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI
|
Qasba, Pradman K.
|
|
2006
|
8 |
1 |
p. E190-E195
|
artikel
|
| 15 |
Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI
|
Qasba, Pradman K.
|
|
|
8 |
1 |
|
artikel
|
| 16 |
Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions
|
Gerber, Basil O.
|
|
2006
|
8 |
1 |
p. E160-E165
|
artikel
|
| 17 |
Opioid ligands with mixed μ/δ opioid receptor interactions: An emerging approach to novel analgesics
|
Ananthan, Subramaniam
|
|
2006
|
8 |
1 |
p. E118-E125
|
artikel
|
| 18 |
Recent progress in the computational prediction of aqueous solubility and absorption
|
Johnson, Stephen R.
|
|
2006
|
8 |
1 |
p. E27-E40
|
artikel
|
| 19 |
Receptors of mammalian trace amines
|
Lewin, Anita H.
|
|
2006
|
8 |
1 |
p. E138-E145
|
artikel
|
| 20 |
Role of bioactivation in drug-induced hypersensitivity reactions
|
Sanderson, Joseph P.
|
|
2006
|
8 |
1 |
p. E55-E64
|
artikel
|
| 21 |
Safety biomarkers and the clinical development of oncology therapeutics: Considerations for cardiovascular safety and risk management
|
Fingert, Howard
|
|
2006
|
8 |
1 |
p. E89-E94
|
artikel
|
| 22 |
Selectivity and potency of cyclin-dependent kinase inhibitors
|
Sridhar, Jayalakshmi
|
|
2006
|
8 |
1 |
p. E204-E221
|
artikel
|
| 23 |
Symbiotic relationship of pharmacogenetics and drugs of abuse
|
Rutter, Joni L.
|
|
2006
|
8 |
1 |
p. E174-E184
|
artikel
|
| 24 |
Targeting opioid receptor heterodimers: Strategies for screening and drug development
|
Gupta, Achla
|
|
2006
|
8 |
1 |
p. E153-E159
|
artikel
|
| 25 |
The chinchilla microdialysis model for the study of antibiotic distribution to middle ear fluid
|
Cheung, Belinda W. Y.
|
|
2006
|
8 |
1 |
p. E41-E47
|
artikel
|
| 26 |
The pharmacokinetics of escitalopram in patients with hepatic impairment
|
Areberg, Johan
|
|
2006
|
8 |
1 |
p. E14-E19
|
artikel
|
Tijdschrift beschrijving